Table 1.
Sera | ELISA HOG(a) | ELISA SODe (b) | WB SODe(c) | Age | Gender | Pathology(d) |
---|---|---|---|---|---|---|
8 | − | + | + | 53 | M | DM-I |
10 | − | + | + | 40 | F | HPG |
26 | − | + | + | 53 | F | DM-I + ICC |
30 | − | + | + | 43 | M | CCF |
40 | − | + | + | 32 | F | HPC |
49 | + | + | − | 43 | M | ICC + DSP |
50 | + | + | + | 39 | F | CCF |
119 | + | + | + | 45 | F | HPG |
122 | + | + | + | 35 | M | DM-II |
133 | − | − | + | 80 | M | DM-II |
141 | − | + | + | 27 | F | RF |
157 | − | + | − | 37 | F | DSP |
173 | − | + | − | 67 | M | DSP |
185 | + | + | + | 33 | F | DSP |
200 | − | + | + | 50 | F | DSP |
203 | + | + | + | 48 | M | HPC |
204 | + | − | − | 54 | F | DM-I + DSP |
205 | − | + | + | 43 | F | CCF |
206 | − | + | + | 27 | F | DSP |
207 | − | + | + | 29 | F | CCF |
212 | − | + | + | 48 | M | HT |
214 | − | + | + | 35 | M | DSP |
215 | − | + | + | 27 | M | DSP |
218 | − | + | + | 39 | M | DM-I |
221 | − | + | + | 40 | F | HPC |
226 | − | − | + | 37 | M | CCF |
229 | − | + | + | 51 | F | CCF |
232 | − | + | + | 42 | F | DM-I |
236 | − | + | + | 44 | M | HPG |
238 | − | + | + | 49 | M | CCF |
240 | + | + | + | 43 | M | CCF |
245 | − | + | + | 43 | F | CCF |
246 | − | + | + | 44 | F | CCF |
247 | − | + | + | 43 | F | RF |
(a)ELISA-HOG: Enzyme-Linked Immunosorbent Assay (ELISA) using total parasite extract (HOG) of T. cruzi as antigen fraction.
(b)ELISA-SODe: Enzyme-Linked Immunosorbent Assay (ELISA) using excreted superoxide dismutase (SODe) by epimastigotes of T. cruzi as antigen fraction.
(c)WB-SODe: Western Blot (WB) using excreted superoxide dismutase (SODe) by epimastigotes of T. cruzi as antigen fraction.
(d)Pathology abreviations: MD-I: mellitus diabetes type 1; MD-II: mellitus diabetes type 2; HPG: hipertrigliceridemia; CCF: chronic cardiac failure; HPC: hypercholesterolemia; DSP: dyslipidemia; RF: renal failure; HT: hyperthyroidism.